United States - English - NLM (National Library of Medicine)

direct rx - tramadol hydrochloride (unii: 9n7r477wck) (tramadol - unii:39j1lgj30j) - tramadol hydrochloride extended-release tablets are indicated for the management of moderate to moderately severe chronic pain in adults who require around-the-clock treatment of their pain for an extended period of time tramadol hydrochloride extended-release tablets should not be administered to patients who have previously demonstrated hypersensitivity to tramadol, any other component of this product or opioids. tramadol hydrochloride extended-release tablets are contraindicated in any situation where opioids are contraindicated, including acute intoxication with any of the following: alcohol, hypnotics, narcotics, centrally acting analgesics, opioids or psychotropic drugs. tramadol hydrochloride extended-release tablets may worsen central nervous system and respiratory depression in these patients. - tramadol hydrochloride extended-release tablet is a mu-agonist opioid. tramadol, like other opioids used in analgesia, can be abused and is subject to criminal diversion. drug addiction is characterized by c

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

healol pharmaceuticals sdn. bhd. - paracetamol; tramadol hydrochloride -

United States - English - NLM (National Library of Medicine)

advanced rx pharmacy of tennessee, llc - tramadol hydrochloride (unii: 9n7r477wck) (tramadol - unii:39j1lgj30j) - tramadol hydrochloride extended-release tablets are contraindicated for: all children younger than 12 years of age [see warnings]. postoperative management in children younger than 18 years of age following tonsillectomy and/or adenoidectomy [see warnings]. tramadol hydrochloride extended-release tablets are also contraindicated in patients with: significant respiratory depression [see warnings] acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see warnings] known or suspected gastrointestinal obstruction, including paralytic ileus [see warnings] hypersensitivity to tramadol (e.g., anaphylaxis) [see adverse reactions] concurrent use of monoamine oxidase inhibitors (maois) or use within the last 14 days [see precautions; drug interactions] indications and usage tramadol hydrochloride extended-release tablets are indicated for the management of pain severe enough to require daily, around-the-clock, long term opioid treatment and for

Ireland - English - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - tramadol hydrochloride; paracetamol - film-coated tablet - 37.5/325 milligram(s) - opioids in combination with non-opioid analgesics; opiods in combination with non-opiod analgesics

Philippines - English - FDA (Food And Drug Administration)

hizon labs inc - paracetamol , tramadol hydrochloride - tablet, film coated - 325mg + 37.5mg

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - tramadol hydrochloride, quantity: 100 mg - injection, solution - excipient ingredients: sodium acetate trihydrate; water for injections - tramadol an solution for injection is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

United States - English - NLM (National Library of Medicine)

watson laboratories, inc. - tramadol hydrochloride (unii: 9n7r477wck) (tramadol - unii:39j1lgj30j) - tablet - 50 mg - tramadol hydrochloride tablets are indicated for the management of moderate to moderately severe pain in adults. tramadol hydrochloride should not be administered to patients who have previously demonstrated hypersensitivity to tramadol, any other component of this product or opioids. tramadol hydrochloride is contraindicated in any situation where opioids are contraindicated, including acute intoxication with any of the following: alcohol, hypnotics, narcotics, centrally acting analgesics, opioids or psychotropic drugs. tramadol hydrochloride may worsen central nervous system and respiratory depression in these patients. tramadol hydrochloride may induce psychic and physical dependence of the morphine-type (μ-opioid). (seewarnings . ) dependence and abuse, including drug-seeking behavior and taking illicit actions to obtain the drug are not limited to those patients with prior history of opioid dependence. the risk in patients with substance abuse has been observed to be higher. tramadol hydrochloride is ass

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

aspire pharma ltd - paracetamol; tramadol hydrochloride - oral tablet - 650mg ; 75mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - paracetamol; tramadol hydrochloride - oral tablet - 650mg ; 75mg

United States - English - NLM (National Library of Medicine)

advanced rx pharmacy of tennessee, llc - tramadol hydrochloride (unii: 9n7r477wck) (tramadol - unii:39j1lgj30j) - indications and usage tramadol hydrochloride extended-release tablets are indicated for the management of pain severe enough to require daily, around-the-clock, long term opioid treatment and for which alternative treatment options are inadequate. limitations of use - because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses, and because of the greater risks of overdose and death with extended-release opioid formulations [see warnings], reserve tramadol hydrochloride extended-release tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics or immediate-release opioids], are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. - tramadol hydrochloride extended-release tablets are not indicated as an as-needed (prn) analgesic. tramadol hydrochloride extended-release tablets are contraindicated for: - all children younger than 12 years of age [see warnings] - post-operative management in c